Please assess the completion status of the following clinical trial:

Trial Title: Magnesium Sulfate in Pregnancy and Postpartum

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Severe hypertensive disorder receiving magnesium sulfate prophylaxis for less than 8 hours at birth.~Exclusion Criteria:~* Complications such as: HELLP syndrome, renal failure, eclampsia, retinal detachment, cerebral edema, pulmonary edema, hypertensive encephalopathy.

- Gender: FEMALE
- Minimum Age: 14 Years
- Maximum Age: 44 Years
- Healthy Volunteers: t

Study Arms:
- Six Hours Postpartum (Type: EXPERIMENTAL): The woman received magnesium sulfate for 6 hours after delivery as prophylaxis to eclampsia.
- Twenty-four hours Postpartum (Type: ACTIVE_COMPARATOR): The woman received magnesium sulfate for 24 hours after delivery as prophylaxis to eclampsia.

Based on this trial design, predict the completion outcome and termination type (if applicable).